inozyme_logo.jpg
Inozyme Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
November 12, 2020 06:00 ET | Inozyme Pharma Inc.
–  Submitted CTA for INZ-701 for the treatment of ENPP1 deficiency to United Kingdom regulatory agency – –  Received Rare Pediatric Disease and Fast Track Designations for INZ-701 for the treatment...
inozyme_logo.jpg
Inozyme Pharma Appoints Kevin B. Johnson, Ph.D., MBA, as Senior Vice President, Regulatory Affairs
November 09, 2020 06:00 ET | Inozyme Pharma Inc.
BOSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal...
22157.jpg
Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2020
October 13, 2020 05:09 ET | Research and Markets
Dublin, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Pharma, Biotech and Diagnostics Asset Purchase Partnering Deals Analysis 2014-2020
October 13, 2020 04:49 ET | Research and Markets
Dublin, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020" report has been added to...
22157.jpg
Global Pharma, Biotech and Diagnostics Option and Evaluation Partnership Terms and Agreements 2014-2020
October 12, 2020 08:49 ET | Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020" report has been added to...
SequelIe
Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing
October 05, 2020 08:00 ET | Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
ResearchDriveLogo.jpg
Global Collagen Peptides Market to Reach Up to $1,169.5 Million and Grow at a CAGR of 8.1% by 2027 - Exclusive Report [196 pages] by Research Dive
October 01, 2020 08:48 ET | Research Dive
New York, USA, Oct. 01, 2020 (GLOBE NEWSWIRE) -- As per a newly published report by Research Dive, the Global Collagen Peptides Market is expected to rise at a CAGR of 8.1% and is estimated to...
ResearchDriveLogo.jpg
Home Infusion Therapy Industry to Make Headways amidst COVID-19 Turmoil - Exclusive Report [165 pages] by Research Dive
September 30, 2020 08:59 ET | Research Dive
New York, USA, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Patients as well as healthcare providers are finding that treatment offered outside of a hospital, especially in the comfort of a patient’s home,...
22157.jpg
Global Life Science Analytics Market (2020 to 2025) - Increasing Focus on Value-Based Medicine Presents Opportunities
September 30, 2020 07:54 ET | Research and Markets
Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) -- The "Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, Clinical trial, R&D,...
avicorelogo.png
HealthTab™ Integrating New Device to Add HbA1c Blood Glucose Testing to Its Real-Time Data Reporting System
September 22, 2020 08:00 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore" or the "Company") is pleased to announce the signing of a Letter of Intent...